Financials Carelabs Co.,Ltd

Equities

A263700

KR7263700007

Software

End-of-day quote Korea S.E. 18:00:00 2024-05-13 EDT 5-day change 1st Jan Change
4,145 KRW +1.72% Intraday chart for Carelabs Co.,Ltd +4.28% -4.38%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 118,122 97,985 145,644 172,360 120,310 84,099
Enterprise Value (EV) 1 124,628 109,331 110,479 181,373 147,059 113,940
P/E ratio 32 x 168 x 29.7 x 138 x -4.54 x -3.36 x
Yield - - - - - -
Capitalization / Revenue 2.17 x 1.43 x 1.9 x 1.83 x 1.37 x 1.03 x
EV / Revenue 2.29 x 1.6 x 1.44 x 1.93 x 1.68 x 1.39 x
EV / EBITDA 20.5 x 18.4 x 13.3 x 35.4 x -55.5 x -15.7 x
EV / FCF -36.7 x -175 x 18 x -4.61 x -43.2 x -19.4 x
FCF Yield -2.72% -0.57% 5.55% -21.7% -2.32% -5.15%
Price to Book 1.98 x 1.56 x 1.49 x 1.68 x 1.42 x 1.23 x
Nbr of stocks (in thousands) 12,337 12,851 17,236 17,236 18,201 19,400
Reference price 2 9,575 7,625 8,450 10,000 6,610 4,335
Announcement Date 3/19/19 3/17/20 3/12/21 3/14/22 3/16/23 3/11/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 54,379 68,300 76,666 93,934 87,607 81,827
EBITDA 1 6,065 5,927 8,328 5,128 -2,650 -7,273
EBIT 1 4,860 3,615 5,760 2,306 -6,681 -11,698
Operating Margin 8.94% 5.29% 7.51% 2.46% -7.63% -14.3%
Earnings before Tax (EBT) 1 4,266 450.7 6,195 3,936 -26,789 -21,648
Net income 1 3,554 582.6 4,329 1,253 -26,124 -24,470
Net margin 6.54% 0.85% 5.65% 1.33% -29.82% -29.9%
EPS 2 299.0 45.50 284.5 72.70 -1,455 -1,289
Free Cash Flow 1 -3,393 -625.7 6,137 -39,325 -3,408 -5,870
FCF margin -6.24% -0.92% 8% -41.86% -3.89% -7.17%
FCF Conversion (EBITDA) - - 73.69% - - -
FCF Conversion (Net income) - - 141.76% - - -
Dividend per Share - - - - - -
Announcement Date 3/19/19 3/17/20 3/12/21 3/14/22 3/16/23 3/11/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 6,505 11,346 - 9,012 26,750 29,841
Net Cash position 1 - - 35,165 - - -
Leverage (Debt/EBITDA) 1.073 x 1.914 x - 1.758 x -10.09 x -4.103 x
Free Cash Flow 1 -3,393 -626 6,137 -39,325 -3,408 -5,870
ROE (net income / shareholders' equity) 8.47% 0.81% 5.29% 1.18% -26.5% -28.6%
ROA (Net income/ Total Assets) 3.69% 1.8% 2.78% 0.87% -2.2% -4.26%
Assets 1 96,213 32,453 155,763 143,650 1,186,479 573,763
Book Value Per Share 2 4,843 4,899 5,689 5,935 4,648 3,533
Cash Flow per Share 2 2,831 1,421 2,550 2,314 1,458 1,224
Capex 1 6,645 1,461 910 44,368 3,576 1,917
Capex / Sales 12.22% 2.14% 1.19% 47.23% 4.08% 2.34%
Announcement Date 3/19/19 3/17/20 3/12/21 3/14/22 3/16/23 3/11/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A263700 Stock
  4. Financials Carelabs Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW